Health Care Reform

Drugmakers cannot replace upfront discounts with their own rebate models without federal approval, although the ruling leaves HHS free to authorize a future system.

The industry group says its reform effort remains on track despite questions about participation, oversight and continuity-of-care protections.

Here are three questions to determine whether considering an unconventional design makes sense.

Budget analysts increased the federal group health tax subsidy value estimate 25% in just three years.

The company hopes early action will keep small employer claims from becoming stop-loss claims.

In a social media post, the president announced a plan to impose a 100% tariff on generic drugs starting in August 2028.